Engineered sgRNA design and preparation method
The present invention provides a DNA-targeting RNA comprising a single-guide RNA (sgRNA) and a ribonucleotide sequence rich in adenine ribonucleotide, and its use in gene editing, and a method for improving the efficiency of sgRNA-mediated gene editing, comprising a step of adding a ribonucleotide sequence rich in adenine ribonucleotide at 3′ end of the sgRNA.
1 . A DNA-targeting RNA, from 5′ to 3′ direction, comprising:
(i) a single-guide RNA (sgRNA); and
(ii) a ribonucleotide sequence rich in adenine ribonucleotide (A) comprising at least 20 ribonucleotides in length, wherein the ribonucleotide sequence is selected from the group consisting of the nucleotide sequences of SEQ ID NOs: 13, 20 and 21.
2 . The DNA-targeting RNA of claim 1 , wherein, the sgRNA from 5′ to 3′ direction, comprises:
a ribonucleotide sequence specifically targeting a DNA sequence, comprising 18-25 ribonucleotides in length; and
a CRISPR effector protein binding moiety,
wherein the CRISPR effector protein is selected from the group consisting of Cas3, Cas8a, Cas5, Cas8b, Cas8c, Cas10d, Cse1, Cse2, Csy1, Csy2, Csy3, GSU0054, Cas10, Csm2, Cmr5, Cas10, Csx11, Csx10, Csf1, Cas9, Csn2, Cas4, Cpf1, C2c1, C2c3 or C2c2 proteins, and functional variants thereof.
3 . The DNA-targeting RNA of claim 2 , wherein the ribonucleotide sequence specifically targeting a DNA sequence is 100% complementary to a target sequence in the DNA.
4 . The DNA-targeting RNA of claim 1 , wherein the DNA is present within a unicellular eukaryote, a plant cell, an invertebrate cell, or a vertebrate cell.
5 . An isolated nucleic acid comprising a nucleotide sequence that encodes the DNA-targeting RNA of claim 1 .
6 . The nucleic acid of claim 5 , comprising a polynucleotide encoding a promoter, the sgRNA and the ribonucleotide sequence rich in adenine ribonucleotide.
7 . The nucleic acid of claim 6 , wherein the promoter is a T7 promoter.
8 . The nucleic acid of claim 7 , wherein the T7 promoter comprises the sequence of nucleotides 1-21 of SEQ ID NO: 4.
9 . The isolated nucleic acid of claim 5 , wherein the isolated nucleic acid further comprises a promoter operably linked to the nucleotide sequence.
10 . An expression vector comprising the nucleic acid of claim 5 .
11 . A method for preparing the DNA-targeting RNA of claim 1 , comprising: (a) providing a nucleic acid that encodes the DNA-targeting RNA; and (b) performing in vitro transcription on the nucleic acid to produce RNA; and (c) isolating and purifying the produced RNA.
12 . The method of claim 11 , wherein the nucleic acid is obtained by PCR amplification and wherein step (a) further comprises:
(i) providing a template primer nucleic acid that encodes a CRISPR effector protein binding moiety;
(ii) providing an upstream primer and a downstream primer, wherein the downstream primer, from 5′ to 3′ direction, comprises a sequence complementary to the ribonucleotide sequence of SEQ ID NO: 13, 20 or 21, and a sequence complementary to partial sequence at 3′ end of the template primer nucleic acid; and the upstream primer, from 5′ to 3′ direction, comprises a nucleotide sequence corresponding to a ribonucleotide sequence specifically targeting a target DNA sequence, and partial sequence at 5′ end of the template primer nucleic acid; and
(iii) performing PCR amplification to obtain a template nucleic acid.
13 . The method of claim 12 , wherein the template primer nucleic acid comprises the DNA sequence of SEQ ID NO: 6.
14 . The method of claim 12 , wherein the downstream promoter comprises the DNA sequence of SEQ ID NO: 5.
15 . A method for improving the efficiency of sgRNA-mediated gene editing, comprising: adding a ribonucleotide sequence rich in adenine ribonucleotide (A) at 3′ end of the sgRNA, the ribonucleotide sequence having at least 20 ribonucleotides in length, wherein the ribonucleotide sequence is selected from the group consisting of the nucleotide sequences of SEQ ID NOs: 13, 20 and 21.
16 . The method of claim 15 , wherein the sgRNA, from 5′ to 3′ direction, comprises:
a ribonucleotide sequence specifically targeting a DNA sequence; and
a CRISPR effector protein binding moiety.
17 . A method of gene editing, comprising introducing the DNA-targeting RNA of claim 1 , and a CRISPR effector protein, into a target cell.